Nevro Corp. Board of Directors

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.

Mr. Kevin R. Thornal

Mr. Kevin R. Thornal

President, CEO & Director

Ms. Shana D. Ross M.B.A.

Ms. Shana D. Ross M.B.A.

Senior VP & Chief Human Resources Officer

Dr. David Caraway M.D., Ph.D.

Dr. David Caraway M.D., Ph.D.

Senior VP & Chief Medical Officer

Mr. Kashif Rashid J.D.

Mr. Kashif Rashid J.D.

Senior VP of Corporate Development & Chief Legal Officer

Mr. Peter A. Socarras

Mr. Peter A. Socarras

VP, General Counsel & Corporate Secretary

Mr. Greg Siller

Mr. Greg Siller

Senior VP & Chief Commercial Officer

Ms. Angeline C. McCabe

Ms. Angeline C. McCabe

Vice President of Investor Relations & Corporate Communications

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.